000 01419 a2200349 4500
005 20250511233150.0
264 0 _c19900315
008 199003s 0 0 eng d
022 _a0021-9738
024 7 _a10.1172/JCI114455
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSantoli, D
245 0 0 _aSuppression of interleukin 2-dependent human T cell growth in vitro by prostaglandin E (PGE) and their precursor fatty acids. Evidence for a PGE-independent mechanism of inhibition by the fatty acids.
_h[electronic resource]
260 _bThe Journal of clinical investigation
_cFeb 1990
300 _a424-32 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAntigens, CD
_xanalysis
650 0 4 _aCells, Cultured
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aFatty Acids
_xmetabolism
650 0 4 _aHumans
650 0 4 _aInterleukin-2
_xmetabolism
650 0 4 _aLymphocyte Activation
_xdrug effects
650 0 4 _aProstaglandins E
_xpharmacology
650 0 4 _aReceptors, Interleukin-2
_xanalysis
650 0 4 _aT-Lymphocytes
_xdrug effects
700 1 _aPhillips, P D
700 1 _aColt, T L
700 1 _aZurier, R B
773 0 _tThe Journal of clinical investigation
_gvol. 85
_gno. 2
_gp. 424-32
856 4 0 _uhttps://doi.org/10.1172/JCI114455
_zAvailable from publisher's website
999 _c2304995
_d2304995